Integrative review: Evidence and clinical perspectives on the use of botulinum toxin type A in the treatment of congenital muscular torticollis

Authors

DOI:

https://doi.org/10.33448/rsd-v14i12.50304

Keywords:

Botulinum Toxin Type A, Congenital Muscular Torticollis, Physiotherapy.

Abstract

Congenital muscular torticollis (CMT) is a condition characterized by sustained and involuntary contraction of the sternocleidomastoid muscle, resulting in structural changes observed from abnormal tilting, rotation, or flexion of the head. It may be associated with cranial asymmetry, with plagiocephaly being its most common form, and functional limitations. Conservative treatment, based on physiotherapy and stretching, shows good results in most cases, but refractory or late-diagnosed situations still challenge clinical practice. Therefore, this study aimed to analyze the available scientific evidence on the application of biophysical therapy (BPT) in the context of congenital muscular torticollis. This is an integrative literature review, conducted in the electronic databases: PubMed (NCBI, US National Library of Medicine) and BVS (BIREME, PAHO/WHO) using terms properly registered in the Medical Subject Headings (MeSH), delimited by publications between 2005 and 2025. The guiding question applied was: what evidence is available on the use of botulinum toxin type A (TxB-A) in the treatment of chronic musculoskeletal disorders (CMD)? Of the 30 studies identified, only 6 met the eligibility criteria. The findings indicate that TxB-A, especially when associated with physiotherapy, is a safe option with high prognostic effectiveness, mainly in cases refractory to conservative treatment or late initiation of treatment. Despite this, the literature still lacks robust clinical trials and standardized protocols that consolidate its large-scale use.

References

Barbosa, R. F. M., Barbosa, L. M., Marcião, L. G. A., Duarte, M. R. F., Lopes, C. S., & Viana, T. L. I. (2024). Perfil clínico de bebês com torcicolo muscular congênito em uma clínica de fisioterapia em Santarém - Pará. Revista Contemporânea, 4(11), e6665. https://doi.org/10.56083/RCV4N11-131

Collins, A., & Jankovic, J. (2006). Botulinum toxin injection for congenital muscular torticollis presenting in children and adults. Neurology, 67(6), 1083-1085. https://doi.org/10.1212/01.wnl.0000237336.65596.2

Oliveira, C. C. A., Fernandes, E. C., Medeiros, K. D. O., Maia, M. C. B., Seabra, E. J. G., & Santos, P. C. (2020). Toxina botulínica: contexto histórico, molecular e de aplicação prática na área da saúde. Revista Brasileira de Educação e Saúde, 10(2), 1-10. https://doi.org/10.18378/rebes.v10i2.7598

Brasil. Diário Oficial da União. (2023). Acórdão nº 609, de 11 de maio de 2023. Brasília. https://www.coffito.gov.br/nsite/wp-content/uploads/2023/05/ACORDAO-No-609-DE-11-DE-MAIO-DE-2023.pdf

Kapoor, K. M., Batra, A., Kaur, A., Kapoor, A., & Papadopoulos, T. (2025). Efficacy and Safety of Botulinum Toxin Type A Injection for Trapezius Muscle Contouring: A Systematic Review. International Journal of Aesthetic Plastic Surgery, 1(1), 76-84. https://doi.org/10.1177/30499240251320906

Kuo, A. A., Tritasavit, S., & Graham, J. M., Jr. (2014). Congenital muscular torticollis and positional plagiocephaly. Pediatrics in review, 35(2), 79-87. https://doi.org/10.1542/pir.35-2-79

Oleszek, J. L., Chang, N., Apkon, S. D., & Wilson, P. E. (2005). Botulinum toxin type a in the treatment of children with congenital muscular torticollis. American journal of physical medicine & rehabilitation, 84(10), 813–816. https://doi.org/10.1097/01.phm.0000179516.45373.c4

Pereira, A. S. et al. (2018). Metodologia da pesquisa científica. [free ebook]. Santa Maria. Editora da UFSM.

Qiu, X., Cui, Z., Tang, G., Deng, H., Xiong, Z., Han, S., & Tang, S. (2020). The Effectiveness and Safety of Botulinum Toxin Injections for the Treatment of Congenital Muscular Torticollis. The Journal of craniofacial surgery, 31(8), 2160–2166. https://doi.org/10.1097/SCS.0000000000006652

Rubio, A. S., Griffet, J. R., Caci, H., Bérard, E., El Hayek, T., & Boutté, P. (2009). The moulded baby syndrome: incidence and risk factors regarding 1,001 neonates. European journal of pediatrics, 168(5), 605–611. https://doi.org/10.1007/s00431-008-0806-y

Sinn, C. N., Rinaldi, R. J.,& McLaughlin, M. J. (2023). Botulinum toxin type A outcomes in infants with refractory congenital muscular torticollis. Journal of pediatric rehabilitation medicine, 16(3), 539–552. https://doi.org/10.3233/PRM-210088

Sytsma, T. T., Terman, R. W., & Brandenburg, J. E. (2016). Custom neck orthosis in combination with onabotulinumtoxinA for the treatment of refractory congenital muscular torticollis: A case report. Journal of pediatric rehabilitation medicine, 9(2), 155–158. https://doi.org/10.3233/PRM-160369

Snyder, H. (2019). Literature review as a research methodology: An overview and guidelines. Journal of Business Research, Elsevier. 104(C), 333-9. https://doi.org/10.1016/j.jbusres.2019.07.039

Published

2025-12-12

Issue

Section

Health Sciences

How to Cite

Integrative review: Evidence and clinical perspectives on the use of botulinum toxin type A in the treatment of congenital muscular torticollis. Research, Society and Development, [S. l.], v. 14, n. 12, p. e93141250304, 2025. DOI: 10.33448/rsd-v14i12.50304. Disponível em: https://rsdjournal.org/rsd/article/view/50304. Acesso em: 2 jan. 2026.